1195 related articles for article (PubMed ID: 28238223)
1. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
[TBL] [Abstract][Full Text] [Related]
2. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.
Natale P; Tunnicliffe DJ; Toyama T; Palmer SC; Saglimbene VM; Ruospo M; Gargano L; Stallone G; Gesualdo L; Strippoli GF
Cochrane Database Syst Rev; 2024 May; 5(5):CD015588. PubMed ID: 38770818
[TBL] [Abstract][Full Text] [Related]
3. Perioperative glycaemic control for people with diabetes undergoing surgery.
Bellon F; Solà I; Gimenez-Perez G; Hernández M; Metzendorf MI; Rubinat E; Mauricio D
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD007315. PubMed ID: 37526194
[TBL] [Abstract][Full Text] [Related]
4. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study.
Ji LN; Pan CY; Lu JM; Li H; Li Q; Li QF; Peng YD; Tian HM; Yao C; Zhao ZG; Zhang RY; Wang XL; Wang L;
Cardiovasc Diabetol; 2013 Aug; 12():118. PubMed ID: 23958390
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
Wexler DJ; de Boer IH; Ghosh A; Younes N; Bebu I; Inzucchi SE; McGill JB; Mudaliar S; Schade D; Steffes MW; Tamborlane WV; Tan MH; Ismail-Beigi F;
JAMA Intern Med; 2023 Jul; 183(7):705-714. PubMed ID: 37213109
[TBL] [Abstract][Full Text] [Related]
7. Robotic versus laparoscopic versus open nephrectomy for live kidney donors.
Kourounis G; Tingle SJ; Hoather TJ; Thompson ER; Rogers A; Page T; Sanni A; Rix DA; Soomro NA; Wilson C
Cochrane Database Syst Rev; 2024 May; 5(5):CD006124. PubMed ID: 38721875
[TBL] [Abstract][Full Text] [Related]
8. Antioxidants for adults with chronic kidney disease.
Colombijn JM; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RW
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD008176. PubMed ID: 37916745
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes.
Gantz I; Okamoto T; Ito Y; Okuyama K; O'Neill EA; Kaufman KD; Engel SS; Lai E;
Diabetes Obes Metab; 2017 Nov; 19(11):1602-1609. PubMed ID: 28449368
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE).
Mathieu C; Barnett AH; Brath H; Conget I; de Castro JJ; Göke R; Márquez Rodriguez E; Nilsson PM; Pagkalos E; Penfornis A; Schaper NC; Wangnoo SK; Kothny W; Bader G
Int J Clin Pract; 2013 Oct; 67(10):947-56. PubMed ID: 23961850
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with the glucose-lowering efficacy of sitagliptin in Japanese patients with type 2 diabetes mellitus: Pooled analysis of Japanese clinical trials.
Tajima N; Eiki JI; Okamoto T; Okuyama K; Kawashima M; Engel SS
J Diabetes Investig; 2020 May; 11(3):640-646. PubMed ID: 31743602
[TBL] [Abstract][Full Text] [Related]
14. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians.
Drake T; Landsteiner A; Langsetmo L; MacDonald R; Anthony M; Kalinowski C; Ullman K; Billington CJ; Kaka A; Sultan S; Wilt TJ
Ann Intern Med; 2024 May; 177(5):618-632. PubMed ID: 38639549
[TBL] [Abstract][Full Text] [Related]
15. Oral adsorbents for preventing or delaying the progression of chronic kidney disease.
Wu HM; Sun HJ; Wang F; Yang M; Dong BR; Liu GJ
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007861. PubMed ID: 25317905
[TBL] [Abstract][Full Text] [Related]
16. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
Lopez LM; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006133. PubMed ID: 24788670
[TBL] [Abstract][Full Text] [Related]
17. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
;
Lancet Diabetes Endocrinol; 2024 May; 12(5):306-319. PubMed ID: 38554713
[TBL] [Abstract][Full Text] [Related]
18. PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study.
Gaiffe E; Crepin T; Bamoulid J; Courivaud C; Büchler M; Cassuto E; Albano L; Chemouny JM; Choukroun G; Hazzan M; Kessler L; Legendre C; Le Meur Y; Ouali N; Thierry A; Anota A; Nerich V; Limat S; Bonnetain F; Vernerey D; Ducloux D
Trials; 2019 Jun; 20(1):375. PubMed ID: 31227028
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.
Capuano A; Sportiello L; Maiorino MI; Rossi F; Giugliano D; Esposito K
Drug Des Devel Ther; 2013; 7():989-1001. PubMed ID: 24068868
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.
Gracia-Ramos AE; Cruz-Dominguez MDP; Madrigal-Santillán EO; Rojas-Martínez R; Morales-González JA; Morales-González Á; Hernández-Espinoza M; Vargas-Peñafiel J; Tapia-González MLÁ
J Diabetes Complications; 2024 May; 38(5):108742. PubMed ID: 38581842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
